Article

Toll-like Receptors Activate Innate and Adaptive Immunity by using Dendritic Cell-Intrinsic and -Extrinsic Mechanisms

Department of Microbiology & Immunology, University of California, San Francisco, CA, 94143, USA.
Immunity (Impact Factor: 19.75). 08/2008; 29(2):272-82. DOI: 10.1016/j.immuni.2008.05.016
Source: PubMed

ABSTRACT Toll-like receptors (TLRs) play prominent roles in initiating immune responses to infection, but their roles in particular cell types in vivo are not established. Here we report the generation of mice selectively lacking the crucial TLR-signaling adaptor MyD88 in dendritic cells (DCs). In these mice, the early production of inflammatory cytokines, especially IL-12, was substantially reduced after TLR stimulation. Whereas the innate interferon-gamma response of natural killer cells and of natural killer T cells and the Th1 polarization of antigen-specific CD4(+) T cells were severely compromised after treatment with a soluble TLR9 ligand, they were largely intact after administration of an aggregated TLR9 ligand. These results demonstrate that the physical form of a TLR ligand affects which cells can respond to it and that DCs and other innate immune cells can respond via TLRs and collaborate in promoting Th1 adaptive immune responses to an aggregated stimulus.

Download full-text

Full-text

Available from: Baidong Hou, Sep 01, 2015
0 Followers
 · 
80 Views
 · 
47 Downloads
  • Source
    • "Therefore, TLR7/TLR9 signaling can also affect pathology in a Type-I IFN independent manner. DCs that lacked the TLR-adaptor protein MyD88 showed an overall decrease in the levels of inflammatory cytokines in the spleen after TLR9 stimulation with CpG [36], [51]. Furthermore, TLR signaling by DCs also affects B cell function as MyD88 deficient DCs had significantly lower levels of IgG2a anti-nucleosome autoAbs [52]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The breakdown in tolerance of autoreactive B cells in the lupus-prone NZM2410-derived B6.Sle1.Sle2.Sle3 (TC) mice results in the secretion of autoantibodies. TC dendritic cells (DCs) enhance B cell proliferation and antibody secretion in a cytokine-dependent manner. However, the specific cytokine milieu by which TC DCs activate B cells was not known. In this study, we compared TC and C57BL/6 (B6) control for the distribution of DC subsets and for their production of cytokines affecting B cell responses. We show that TC DCs enhanced B cell proliferation through the production of IL-6 and IFN-γ, while antibody secretion was only dependent on IL-6. Pre-disease TC mice showed an expanded PDCA1+ cells prior to disease onset that was localized to the marginal zone and further expanded with age. The presence of PDCA1+ cells in the marginal zone correlated with a Type I Interferon (IFN) signature in marginal zone B cells, and this response was higher in TC than B6 mice. In vivo administration of anti-chromatin immune complexes upregulated IL-6 and IFN-γ production by splenic DCs from TC but not B6 mice. The production of BAFF and APRIL was decreased upon TC DC stimulation both in vitro and in vivo, indicating that these B cell survival factors do not play a role in B cell modulation by TC DCs. Finally, TC B cells were defective at downregulating IL-6 expression in response to anti-inflammatory apoptotic cell exposure. Overall, these results show that the TC autoimmune genetic background induces the production of B cell-modulating inflammatory cytokines by DCs, which are regulated by the microenvironment as well as the interplay between DC.
    PLoS ONE 08/2014; 9(8):e102151. DOI:10.1371/journal.pone.0102151 · 3.23 Impact Factor
  • Source
    • "Fu (National University of Singapore, Singapore; Kano et al., 2003). MyD88 flox mice were provided by A. DeFranco (University of California, San Francisco, CA; Hou et al., 2008). All these transgenic mice used backcrossed 10 times to C57/BL6 background. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-grade systemic inflammation is often associated with metabolic syndrome, which plays a critical role in the development of the obesity-associated inflammatory diseases, including insulin resistance and atherosclerosis. Here, we investigate how Toll-like receptor-MyD88 signaling in myeloid and endothelial cells coordinately participates in the initiation and progression of high fat diet-induced systemic inflammation and metabolic inflammatory diseases. MyD88 deficiency in myeloid cells inhibits macrophage recruitment to adipose tissue and their switch to an M1-like phenotype. This is accompanied by substantially reduced diet-induced systemic inflammation, insulin resistance, and atherosclerosis. MyD88 deficiency in endothelial cells results in a moderate reduction in diet-induced adipose macrophage infiltration and M1 polarization, selective insulin sensitivity in adipose tissue, and amelioration of spontaneous atherosclerosis. Both in vivo and ex vivo studies suggest that MyD88-dependent GM-CSF production from the endothelial cells might play a critical role in the initiation of obesity-associated inflammation and development of atherosclerosis by priming the monocytes in the adipose and arterial tissues to differentiate into M1-like inflammatory macrophages. Collectively, these results implicate a critical MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.
    Journal of Experimental Medicine 04/2014; 211(5). DOI:10.1084/jem.20131314 · 13.91 Impact Factor
  • Source
    • "TLR-mediated signals play prominent roles in initiating immune responses to infection [38]. In mammalian tissues, TLRs are highly expressed by resident immune cells, including dendritic cells, tissue macrophages, and mast cells and to a lesser degree by other cell types including fibroblasts, epithelial cells, and endothelial cells [39]. Upon binding ligands, all known TLRs induce the production of inflammatory cytokines including interferon (IFN)-α, IFN-β, IL-12(p40), TNF-α, IL-6, and IL-1β, which attract innate immune cells and/or promote the initiation and polarization of adaptive immune responses [40] [41] [42]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although Toll-like receptors (TLRs) have been implicated in the regulation of stem cell functions, their role in osteogenic differentiation of adipose-derived stromal cells (ASCs) has not been reported. We found that ASCs express a restricted subset of TLRs, including TLR1-TLR5, and that TLR agonists such as Pam3CSK4 (TLR1/2 agonist), poly-IC (TLR3 agonist), LPS (TLR4 agonist), and flagellin (TLR5 agonist), but not R848 (TLR7/8 agonist), consistently induced osteogenic differentiation in murine-derived ASCs, which coincided with the TLR expression pattern of ASCs. Cytokine expression profiles induced by TLR agonists and results from subsequent functional assays indicated that interleukin-6 (IL-6) together with soluble IL-6 receptor (sIL-6R) enhanced osteogenic differentiation of ASCs by activating STAT3. Small interfering RNA (siRNA)-mediated STAT3-silencing blunted osteogenesis and the expression of osteogenic markers, whereas STAT3 overexpression resulted in an increase in osteogenesis. Consistently, IL-6 inhibitor treatment reduced osteogenesis, STAT3 phosphorylation, and expression of osteogenic markers including osterix. Chromatin immunoprecipitation (ChIP) assays indicated that STAT3 binding to the STAT3-binding sites on the osterix promoter increased during IL-6-stimulated osteogenesis. Our results thus establish TLRs as novel regulators of ASCs which signal through IL-6/STAT3 pathway and induce osterix expression as a part of the osteogenesis.
    Biochimica et Biophysica Acta 07/2013; 1833(12). DOI:10.1016/j.bbamcr.2013.06.025 · 4.66 Impact Factor
Show more